MedTrace Logo

Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium

NCT02785653 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-06-09

No results posted yet for this study

Summary

This study evaluates the potentiation of muscle relaxation caused by rocuronium by inhalational agent sevoflurane. Half the patients will be ventilated with oxygen ,nitrous oxide and sevoflurane during induction of anaesthesia and half will be ventilated only with oxygen and nitrous oxide.

Conditions

  • Muscle Relaxation Caused by Sevoflurane

Interventions

DRUG

Sevoflurane

Patients were ventilated with 2 % inspired concentration of sevoflurane in a fresh gas flow of 5 litres containing 66.6% nitrous oxide and 33.3% percent of oxygen

DRUG

Rocuronium

rocuronium 0.6mg per kg body weight was given intravenously after induction of anaesthesia

Sponsors & Collaborators

  • Jaslok Hospital and Research Centre

    collaborator OTHER

  • Maharashtra University of Health Sciences

    lead OTHER

Principal Investigators

  • Nazmeen I Sayed, DNB(Anaes) · Lokmanya Tilak Municipal Medical College and Hospital

  • Dipankar Dasgupta, MD(Anaes) · Jaslok Hospital and Research Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2006-11-30
Completion
2006-11-30

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02785653 on ClinicalTrials.gov